Conversion to CREXONT® in the RISE-PD Phase 3 Trial Improved Aspects of Sleep as Measured by the Parkinson’s Disease Sleep Scale-2 (PDSS-2) (P11-5.004)
To assess whether converting patients with Parkinson’s disease (PD) to CREXONT improves Parkinson’s Disease Sleep Scale-2 (PDSS-2) total and sub-scale scores.
Authors
- Zachary A. Grieb (ORCID: https://orcid.org/0000-0003-1165-0976)
- Robert Hauser
- William G. Ondo (ORCID: https://orcid.org/0000-0001-6090-4261)
- Stanley E. Fisher
- Ghazal Banisadr
Institutions
- Amneal (India) (IN)
- Centre for Movement Disorders (CA)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211334
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00